Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - europepmc.org
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele, T Grabauskas… - Proceedings of the …, 2021 - JSTOR
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
[HTML][HTML] Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - ncbi.nlm.nih.gov
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - asu.elsevierpure.com
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele… - … of the National …, 2021 - utsouthwestern.elsevierpure.com
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - ui.adsabs.harvard.edu
Release of oligomeric/fibrillar α-synuclein (αSyn) from damaged neurons contributes to
neuronal cell death in Parkinson's disease and other neurodegenerative disorders in part …
neuronal cell death in Parkinson's disease and other neurodegenerative disorders in part …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
D Trudler, K Nazor, Y Eisele… - Proceedings of the …, 2021 - escholarship.org
Parkinsons disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - europepmc.org
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …